![](/img/cover-not-exists.png)
BMS bets on targeting IL-8 to enhance cancer immunotherapies
Dolgin, ElieVolume:
34
Language:
english
Journal:
Nature Biotechnology
DOI:
10.1038/nbt1016-1006
Date:
October, 2016
File:
PDF, 2.84 MB
english, 2016